Terms: = Ovarian cancer AND DROSHA, HSA242976, 29102, RNASEN, ENSG00000113360, Q9NRR4, RNASE3L, RN3, RANSE3L, Etohi2 AND Treatment
3 results:
1. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway.
Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST
Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254
[TBL] [Abstract] [Full Text] [Related]
2. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.
Rupaimoole R; Ivan C; Yang D; Gharpure KM; Wu SY; Pecot CV; Previs RA; Nagaraja AS; Armaiz-Pena GN; McGuire M; Pradeep S; Mangala LS; Rodriguez-Aguayo C; Huang L; Bar-Eli M; Zhang W; Lopez-Berestein G; Calin GA; Sood AK
Oncogene; 2016 Aug; 35(33):4312-20. PubMed ID: 26725326
[TBL] [Abstract] [Full Text] [Related]
3. Application of microRNA in diagnosis and treatment of ovarian cancer.
Banno K; Yanokura M; Iida M; Adachi M; Nakamura K; Nogami Y; Umene K; Masuda K; Kisu I; Nomura H; Kataoka F; Tominaga E; Aoki D
Biomed Res Int; 2014; 2014():232817. PubMed ID: 24822185
[TBL] [Abstract] [Full Text] [Related]